Gapping down
In reaction to disappointing earnings/guidance:
- EB -32.5%, ABMD -14.5%, NVTR -13.7%, FLR -13.2%, MITK -12% (also ends review of strategic alternatives), CASA -11%, WLL -10.3%, CREE -9.5%, CDAY -7.3% (also appoints Christopher Armstrong to the position of COO), WTI -7.3%, FARO -6.4%, W -5.8%, HGV -4.7%, SQ -4.5%, PPC -4.5%, PDCE -4.1%, RYI -4%, SWM -4%, VNDA -3.8%, TYL -3.1%, SM -3%, CAR -2.8%, FIVN -2.8%, LPI -2.7%, BWXT -2.6%, HST -2.5%, APA -2.2%, AGI -2.2%, NLY -1.9%, AEGN -1.9%, APTV -1.9%, MD -1.6%, OI -1.4%, LMAT -1.3%, AM -1.1%, BLL -1.1%, AYX -1%, NTCT -1%
Other news:
- XBIT -4% (enters into Equity Distribution Agreement providing for the sale of up to 4,334,453 shares of Common Stock from time to time)
- ZLAB -3.8% (announces proposed public offering of 5.0 mln ADSs)
- VCYT -2.7% ( commences underwritten public offering of 5 mln shares of its common stock)
- RMTI -2.1% (announces preliminary recommendation from CMS to establish a new J-code for Triferic powder packet)
- GWRE -0.9% (says audited consolidated financial statements for FY18 & FY17 should no longer be relied upon, expects to report material weakness in internal control over financial reporting related to the matter)
- WAB -0.9% (prices upsized public offering of 22.0 mln shares by selling stockholder of common stock at $73.50)
Analyst comments:
- MOS -2.6% (downgraded to Neutral from Buy at BofA/Merrill)
- EL -1.4% (downgraded to Sector Perform from Outperform at RBC Capital Mkts)
- ADSW -1.1% (downgraded to Neutral from Buy at UBS)
- DX -0.7% (downgraded to Neutral from Buy at Ladenburg Thalmann)
- SMG -0.7% (downgraded to Underperform from Neutral at BofA/Merrill)